(Telestock) – Shedir Pharma Groupthe operating holding company of the Shedir Pharma Group, a leading operator active in the nutraceutical, dermocosmetic, medical device and pharmaceutical sectors, announces the completion by its wholly owned subsidiary Dymalife Pharmaceutical
of the acquisition of the branch of the company consisting of 7 drugs and the related stocks.
The operation, explains a note, was finalized with Alfasigma, one of the main Italian pharmaceutical companies with a strong international presence.
The equivalent expected for the purchase of the 7 drugs was set at 1.1 million euros in addition to the value of the stocks of approximately 300 thousand euros. The operation was financed through the use of the liquid assets of the Group treasury.